drugset / Trial / NCT06692673

Linaclotide for Colonoscopy Bowel Prep

NCT06692673

Phase 1/2 Recruiting 10 enrolled University of Florida
NaSingle-groupOpen-labelPrevention

Summary

The goal of this clinical trial is to learn if drug Linaclotide can be used as a single agent regimen to adequately prepare bowel for colonoscopy. The main question it aims to answer is: Does drug Linaclotide with Gatorade provide adequate bowel preparation for colonoscopy instead of the standard 4 Liters of Polyethylene glycol (PEG)? Participants will: Take one 290mg dose of Linaclotide 36 hours before the procedure and One 290mg dose of Linaclotide 8 hours before the procedure + 2 Liters of Gatorade and a clear liquid diet 24 hours before the procedure. As per standard of care, all patients will be made Nil Per Oral (NPO) starting midnight before the procedure. The colonoscopy report will then be reviewed for Boston Bowel Preparation Score (BBPS) as a marker of bowel preparation quality, insertion time as a marker of procedure difficulty as well as noted pathology and any complications or physician noted comments.

Timeline

Start
2025-12-01
Primary completion
2026-04-30
Completion
2026-07-28

Drugs

EvaluationDrugModalityDoseRoute
Subject Linaclotide Peptide 290 mg

Indications

No indication recorded.